On Tuesday, August 7,
executives and guests of Taro Pharmaceuticals
(NYSE: TARO), a multinational, science-based pharmaceutical company, will visit the New York Stock Exchange (NYSE) to mark the company’s March 22, 2012 stock listing on the NYSE.
To celebrate the occasion, CEO James H. Kedrowski, joined by the members of the company's management team, will ring the NYSE Opening Bell.
Tuesday, August 7, 2012
NYSE Security Checkpoint/Tent at corner of Exchange Place and Broad Street
9:00 a.m. Media escorted into building
9:30 a.m. The Opening Bell Rings
Media interested in covering the bell ringing MUST contact Judy Shaw at 212.656.4290 or email at firstname.lastname@example.org.
Photos available via Associated Press/New York (212.621.1902), Reuters America (646.223.6285), Getty Images (646.613.4141), Bloomberg Photo (212.617.3420) and European Press Agency (917.670.1323). The Opening Bell (starting at 9:25 a.m.) feed is available via Ascent loop #4009. Media seeking footage via The Switch should contact NYSE Broadcast at 212.656.5483.
For photos and video of the bell ringing, connect with NYSE Euronext on Facebook (NYSE Euronext-Official Site), YouTube (nysetv1), and Twitter (@NYSEEuronext), #NYSEBell.
About Taro Pharmaceuticals (NYSE: TARO)
Taro Pharmaceutical Industries Ltd. is a multinational, science-based pharmaceutical company, dedicated to meeting the needs of its customers through the discovery, development, manufacturing and marketing of the highest quality healthcare products. For further information on Taro Pharmaceutical Industries Ltd., please visit Taro’s website at www.taro.com. (Source: Taro Pharmaceuticals)